Back to the immunology drawing board, AbbVie inks discovery deal with old Allergan partner
Allergan’s neurology-focused R&D pact with Sosei Heptares hasn’t been all roses, but the BD team at AbbVie found enough to like about the G …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.